A study presented at the American College of Foot and Ankle Surgeons suggests that application of CLARIX FLO, a matrix of amniotic membrane and umbilical cord, could be beneficial for patients with plantar fasciitis.
According to the researchers—Dr Ryan Scott of The CORE Institute in Phoenix, and Dr David Garras of Midwest Orthopaedic Consultants and an assistant professor at University of Illinois at Chicago—injections of the CLARIX FLO matrix helped decrease pain from baseline and improve overall functional recovery among the 43 patients who participated in the study.
The duo notes that increasing the dose resulted in better results, per a media release from Amniox Medical Inc.
In the study, “Particulate Umbilical Cord/Amniotic Membrane for the Treatment of Plantar Fasciitis,” the scientists injected the 43 patients with the matrix and then followed them for 18 weeks.
“These study results continue to demonstrate the compelling therapeutic benefits of a human tissue matrix composed of both umbilical cord and amniotic membrane,” says Tom Dugan, chief executive officer of Amniox Medical, in the release.
“Furthermore, Amniox Medical is the only provider of an injectable form of umbilical cord, allowing for the non-invasive delivery of the biological components of umbilical cord, which have proven regenerative properties,” he adds.
The study was presented recently at the American College of Foot and Ankle Surgeons meeting in Las Vegas.
[Source(s): Amniox Medical Inc, Business Wire]